Chenghong Peng
Overview
Explore the profile of Chenghong Peng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
135
Citations
2536
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Fu N, Jiang Y, Xu Z, Yang M, Peng C, Deng X, et al.
Aging Cancer
. 2023 Jan;
3(3-4):161-168.
PMID: 36718230
Background: The coronavirus disease 2019 (COVID-19) pandemic resulted in enormous medical and economic burden worldwide during the past 3 years. The vaccination was deemed the effective option to prevent the...
12.
Shen Z, Chen H, Zhao S, Ji Y, Zhou Y, Weng Y, et al.
Ann Surg Oncol
. 2022 Oct;
30(3):1474-1482.
PMID: 36305986
Background: The short-term outcome and long-term survival of pancreaticoduodenectomy with additional para-aortic dissection (PAD) for patients with resectable pancreatic cancer remain obscure. Patients And Methods: Consecutive patients who underwent radical...
13.
Tong H, Liu X, Peng C, Shen B, Zhu Z
Cell Signal
. 2022 Oct;
101:110498.
PMID: 36273753
Kinetochore associated 1 (KNTC1) encodes a kinetochore component in Rod-Zwilch-ZW10 (RZZ) complex which is essential for the segregation of sister chromatids during mitosis and participates in the spindle checkpoint. Recent...
14.
Wang W, Lou W, Xu Z, Chen H, Shen Z, Deng X, et al.
J Adv Res
. 2022 Oct;
49:151-157.
PMID: 36198383
Introduction: The value of extended lymphadenectomy in pancreatoduodenectomy (PD) has been discussed by five randomized controlled studies. However, the limitations in the studies made their conclusions not sufficiently reliable. Objectives:...
15.
Lin J, Wang X, Zhai S, Shi M, Peng C, Deng X, et al.
J Hematol Oncol
. 2022 Sep;
15(1):128.
PMID: 36068586
Background: circRNA has been established to play a pivotal role in tumorigenesis development in a variety of cancers; nevertheless, the biological functions and molecular mechanisms of hypoxia-induced exosomal circRNAs in...
16.
Feng Z, Li K, Qin K, Liang J, Shi M, Ma Y, et al.
J Hematol Oncol
. 2022 Aug;
15(1):112.
PMID: 35978332
Background: Although a substantial increase in the survival of patients with other cancers has been observed in recent decades, pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest diseases. No...
17.
Weng Y, Shen Z, Gemenetzis G, Jin J, Chen H, Deng X, et al.
Int J Surg
. 2022 Aug;
104:106801.
PMID: 35934284
Background: Limited data are available regarding long-term oncological outcomes in patients with pancreatic ductal adenocarcinoma (PDAC) who undergo robotic pancreatectomy (RP). Method: All patients who underwent RP and open pancreatectomy...
18.
Wang L, Liu Y, Dai Y, Tang X, Yin T, Wang C, et al.
Gut
. 2022 Jun;
72(5):958-971.
PMID: 35688610
Objective: Innate immunity plays important roles in pancreatic ductal adenocarcinoma (PDAC), as non-T-cell-enriched tumour. Neutrophils are major players in innate immune system. Here, we aimed to explore the heterogeneity and...
19.
Shen Z, Chen H, Wang W, Xu W, Zhou Y, Weng Y, et al.
Int J Surg
. 2022 May;
102:106638.
PMID: 35500881
Objective: Clinically relevant postoperative pancreatic fistula (CR-POPF) remains the major cause of morbidity following pancreaticoduodenectomy (PD). Several model score systems such as the Fistula Risk Score (FRS) have been developed...
20.
Liu Y, Wang X, Zhu Y, Cao Y, Wang L, Li F, et al.
Clin Transl Med
. 2022 Feb;
12(2):e654.
PMID: 35184402
Background: Tumour-associated macrophages (TAMs) play an important role in promoting the progression of pancreatic ductal adenocarcinoma (PDAC). Here, we aimed to study the epigenetic mechanisms in regulating pro-tumour M2-polarised TAMs...